Medicine / D-0806-2026
U.S. Food and Drug AdministrationD-0806-2026
MYXREDLIN, Insulin Human in 0.9% Sodium Chloride Injection, 100 units/100 mL (1 unit/mL), Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC…
Class II Distributed nationwide or U.S.-wide
Status: Ongoing
What was recalled
MYXREDLIN, Insulin Human in 0.9% Sodium Chloride Injection, 100 units/100 mL (1 unit/mL), Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0126-12.
Recalling firm
Baxter Healthcare Corporation
Reason for recall
CGMP Deviations
Where it went
US Nationwide; Puerto Rico; and Chile.
Shown as U.S. Food and Drug Administration published it (shortened where marked …). Recall Shelf does not change recall facts and is not affiliated with the agency.